retatrutide trial results The experimental GLP-1 drug 'reta' also improved blood sugar and heart health metrics. But side effects led more than 1 in 10 to drop out of trials early: https://bit.ly/4x6Aexb Retatrutide Severe Obesity Trial Shows

Recent study results shared at the Endocrine Society meeting ENDO 2026 indicate that semaglutide was linked to higher weight loss and a 15% decrease in broken bones when it was compared to other weight loss medications

These medications effectively slow gastric emptying, which has raised concerns regarding the risk of residual gastric volume (RGV) and potential pulmonary aspiration during procedures requiring sedation

What do they expect before starting versus what they experience after

limited direct data Clinical Markers Higher-Risk Groups Individuals with diarrhoea Low whole-food intake Pre-existing suboptimal intake 4.5 Calcium Physiological Role Calcium is essential for: Bone mineralisation Neuromuscular signalling Vascular function Hormonal secretion Dietary calcium is obtained primarily from: Dairy products Fortified plant milks Leafy greens Small fish with bones Why GLP-1 Therapy May Influence Calcium Status Potential mechanisms include: Reduced overall food intake Reduced dairy intake due to nausea or early satiety Reduced dietary fat intake affecting absorption of vitamin D (indirect impact) GLP-1 receptor agonists do not directly impair calcium transporters in the intestine